22nd Century Group, Inc. (OTCMKTS:XXII) Keeps the Climb
Slow and steady, this is the recipe for 22nd Century Group, Inc. (OTCMKTS:XXII), which managed to avoid the mid-week reversal that affected several of the more active tickers. XXII stands at $1.27 with a gain of 6% on moderate volumes of $370,000. 
So far, the news of the sale of warrants has not had a negative effect, or the climb of the ticker has not reached a satisfying point at which profit-taking could resume. On the plus side, the company is not inflated by a paid promotion, preserving the ticker from even more disproportionate moves. 
Before the warrant news, XXII had the following resources to expand in Europe:
- $278,000 Cash
- $2.9 million Total assets
- $1.8 million Current liabilities
- $10 million Total liabilities
- Zero revenues
- $2.5 million Net loss
XXII slumped significantly at the beginning of the month, and in the past six trading days managed to recover the losses. So far, buying is relatively calm, not threatening with sudden sell-offs. Daily volumes are mostly below 500,000 shares.
In comparison, the climb for similarly priced ticker Liberator Medical Holdings, Inc. (OTCBB:LBMH) happened on sharper interest and higher volumes, but the peak near $1.90 was followed by a cliff drop. This rather solid company also overshot the chances it could hold on to a higher ticker price.
Vapor Corp. (OTCMKTS:VPCO), the seller of electronic cigarettes, shows another scenario, a rather solid sideways drift after the best days passed. The company capitalized on the novel appeal of smokeless nicotine. VPCO is similar in that it also rose of its own merit, without the help of promoters.
XXII has a slower business model, creating its products from scratch, by modifying tobacco plants for lower nicotine content. To the company’s credit, the history dates back to 1998. XXII is defined as attractive due to low free float, with just 17 million out of 42 million shares outstanding.
